High-tech imaging contributing to overdiagnosis of low-risk thyroid cancers

August 27, 2013

An increasing gap between the incidence of thyroid cancer and deaths from the disease suggests that low-risk cancers are being overdiagnosed and overtreated, a study from the Mayo Clinic Center for the Science of Health Care Delivery finds. The study appears in the current issue of the British Medical Journal.

"High tech imaging technologies such as ultrasound, CT and MRI can detect very small many of which are slow growing papillary thyroid cancers, says the study's lead author Juan Pablo Brito, M.B.B.S. an endocrine fellow and scholar at Mayo Clinic. "This is exposing patients to unnecessary and harmful treatments that are inconsistent with their prognosis."

Dr. Brito says the surgical removal of all or part of the is a costly procedure and includes a risk of complications such as low calcium levels and nerve injury. Surgical removal procedures in the United States have tripled in the past 30 years—from 3.6 per 100,000 people in 1973 to 11.6 per 100,000 people in 2009.

"Uncertainty about the benefits and harms of immediate treatment for low-risk should spur clinicians to engage patients in shared decision-making to ensure treatment is consistent with the research evidence and patient goals," Dr. Brito says.

To help provide context for patients, Dr. Brito recommends the development of a new term that connotes a favorable prognosis for low-risk thyroid cancers, such as microPapillary Lesions of Indolent Course (microPLIC). A new term would make it easier for clinicians to offer patients the choice of active surveillance instead of immediate and often intensive treatment. He also calls for research to identify the appropriate care for these patients.

Explore further: Removal of lymph nodes during surgery for thyroid cancer may be beneficial

More information: www.bmj.com/cgi/doi/10.1136/bmj.f4706

Related Stories

The Medical Minute: Thyroid cancer on the rise

September 21, 2012

September is Thyroid Cancer Awareness Month. With cases on the rise locally, nationally and globally, Dr. David Goldenberg, director of Head and Neck Surgery at Penn State Hershey Medical Center, hopes people will become ...

Thyroid cancer cases double in 20 years, report finds

December 14, 2012

The number of people diagnosed with thyroid cancer in England has doubled since the early 1990s, according to a new report published by the National Cancer Intelligence Network (NCIN) today (Friday).

'Gene signature' test diagnoses benign thyroid growths

June 17, 2013

A new genetic test accurately and consistently diagnoses benign growths, or nodules, on the thyroid gland, according to a study from Chile. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting ...

Thyroid cancer—rising most rapidly among insured patients

July 1, 2013

The rapid increase in papillary thyroid cancer in the US, may not be linked to increase in occurrence, according to a head and neck surgeon at Dartmouth-Hitchcock Norris Cotton Cancer Center, instead it may be linked to an ...

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.